Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting Xience V stents: two-year clinical outcome in the gender-stratified randomized, controlled TWENTE trial
Year: 2013
Type: conference-abstract
Source: European Heart Journal
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2332933734
